Cargando…
A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syn...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034704/ https://www.ncbi.nlm.nih.gov/pubmed/32117004 http://dx.doi.org/10.3389/fneur.2020.00031 |
_version_ | 1783499926375759872 |
---|---|
author | Hochmeister, Sonja Gattringer, Thomas Asslaber, Martin Stangl, Verena Haindl, Michaela Tanja Enzinger, Christian Höftberger, Romana |
author_facet | Hochmeister, Sonja Gattringer, Thomas Asslaber, Martin Stangl, Verena Haindl, Michaela Tanja Enzinger, Christian Höftberger, Romana |
author_sort | Hochmeister, Sonja |
collection | PubMed |
description | Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syndromes such as optic neuritis, myelitis, and brainstem encephalitis. Most often, the presence of MOG-Abs is associated with a more benign clinical course and a good response to steroids. Here, we present a case report of a previously healthy 52-year-old female patient with fulminant demyelinating encephalitis, leading to death within a week after the first presenting symptoms from a massive brain edema irresponsive to high-dose intravenous steroids as well as osmotic therapy. The final diagnosis was only made postmortem after serum anti-MOG-Abs results were available. Histopathological analysis of the brain revealed extensive, predominantly cortical demyelinating lesions in the frontal, temporal, and parietal lobes with intracortical, leukocortical, and subpial plaques, associated with pronounced perivenous deposition of activated complement complex as well as features of acute MS characterized by destructive lesions. |
format | Online Article Text |
id | pubmed-7034704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70347042020-02-28 A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies Hochmeister, Sonja Gattringer, Thomas Asslaber, Martin Stangl, Verena Haindl, Michaela Tanja Enzinger, Christian Höftberger, Romana Front Neurol Neurology Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syndromes such as optic neuritis, myelitis, and brainstem encephalitis. Most often, the presence of MOG-Abs is associated with a more benign clinical course and a good response to steroids. Here, we present a case report of a previously healthy 52-year-old female patient with fulminant demyelinating encephalitis, leading to death within a week after the first presenting symptoms from a massive brain edema irresponsive to high-dose intravenous steroids as well as osmotic therapy. The final diagnosis was only made postmortem after serum anti-MOG-Abs results were available. Histopathological analysis of the brain revealed extensive, predominantly cortical demyelinating lesions in the frontal, temporal, and parietal lobes with intracortical, leukocortical, and subpial plaques, associated with pronounced perivenous deposition of activated complement complex as well as features of acute MS characterized by destructive lesions. Frontiers Media S.A. 2020-02-14 /pmc/articles/PMC7034704/ /pubmed/32117004 http://dx.doi.org/10.3389/fneur.2020.00031 Text en Copyright © 2020 Hochmeister, Gattringer, Asslaber, Stangl, Haindl, Enzinger and Höftberger. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Hochmeister, Sonja Gattringer, Thomas Asslaber, Martin Stangl, Verena Haindl, Michaela Tanja Enzinger, Christian Höftberger, Romana A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies |
title | A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies |
title_full | A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies |
title_fullStr | A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies |
title_full_unstemmed | A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies |
title_short | A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies |
title_sort | fulminant case of demyelinating encephalitis with extensive cortical involvement associated with anti-mog antibodies |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034704/ https://www.ncbi.nlm.nih.gov/pubmed/32117004 http://dx.doi.org/10.3389/fneur.2020.00031 |
work_keys_str_mv | AT hochmeistersonja afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT gattringerthomas afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT asslabermartin afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT stanglverena afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT haindlmichaelatanja afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT enzingerchristian afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT hoftbergerromana afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT hochmeistersonja fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT gattringerthomas fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT asslabermartin fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT stanglverena fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT haindlmichaelatanja fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT enzingerchristian fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies AT hoftbergerromana fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies |